Harbin Pharmaceutical Group Co., Ltd. (600664.SS) SHH
3.27
-0.06(-1.80%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.91B |
| Enterprise Value | 8.41B |
| P/E Ratio | 26.75 |
| PEG Ratio | -0.5 |
| Price/Sales Ratio | 0.52 |
| Price/Book Ratio | 1.41 |
| Enterprise/Revenue | 0.49 |
| Enterprise/EBITDA | 13.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.03 |
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 15.96B |
| Revenue/Share | 6.34 |
| Gross Profit | 4.15B |
| EBITDA | 924.41M |
| Net Income | 361.6M |
| Diluted EPS | 0.14 |
Balance Sheet
| Total Cash | 3.18B |
| Total Cash/Share | 1.26 |
| Total Debt | 2.78B |
| Total Debt/Equity | 0.48 |
| Current Ratio | 1.45 |
| Book Value Per Share | 2.63 |
Price History
| 52-Week Change | -15.86 |
| 52-Week High | 4.88 |
| 52-Week Low | 3.2 |
| Moving Average 50 Days | 3.66 |
| Moving Average 200 Days | 3.61 |
Statistics
| Average Volume | 112.48M |
| Shares Outstanding | 2.52B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.05 |
| Last Split Factor | 13:10 |
| Last Split Date | April 06, 2016 |
